TLC-6740

· OrsoBio, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TLC-6740, covering 2025-12-18 to 2025-12-18. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1/1b Study of TLC-6740 in Healthy Subjects and Subjects With Obesity, With or Without Diabetes [Phase 1]